Aerovate Therapeutics, Inc.

AVTE · NASDAQ
Analyze with AI
$2.68+$0.00 (+0%)
At close:Apr 28, 2025, 8:00 PM UTC
$2.68+$0.00 (+0%)
After hours:Apr 28, 2025, 8:00 PM UTC
P/E TTM-10.33
P/B TTM3.76
P/S TTM0
Dividend Yield14.09%
EPS-$59.50
Beta0.946
Valuation
PEG Ratio-0.16
FCF Yield-13.80%
EV / EBITDA-7.77
Quality
ROIC-36.11%
Gross Margin0.00%
Cash Conv. Ratio0.71
Growth
Revenue 3Y CAGR
FCF Growth-25.08%
Safety
Net Debt / EBITDA0.76
Interest Coverage0.00
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle-19,710.00

Aerovate Therapeutics, Inc. (AVTE) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Aerovate Therapeutics, Inc. (AVTE) stock price today?

As of Apr 28, 2025, 8:00 PM UTC, Aerovate Therapeutics, Inc. (AVTE) stock is trading at $2.68. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date AVTE stock quotes for informed trading decisions.

What is Aerovate Therapeutics, Inc.'s market capitalization?

Aerovate Therapeutics, Inc. (AVTE) has a market capitalization of approximately $77.7M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Aerovate Therapeutics, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the AVTE stock price changes.

What is the 52-week range for Aerovate Therapeutics, Inc. stock?

Aerovate Therapeutics, Inc. (AVTE) stock has traded in a 52-week range of $2.63 — $884.98. The 52-week range shows the highest and lowest prices at which AVTE traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Aerovate Therapeutics, Inc. stock price to this range provides context for recent price action.

How much trading volume does Aerovate Therapeutics, Inc. stock have?

Aerovate Therapeutics, Inc. (AVTE) stock recently traded approximately 981.8K shares. Trading volume indicates market liquidity and investor interest in AVTE. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Aerovate Therapeutics, Inc. stock.

Does Aerovate Therapeutics, Inc. pay dividends to shareholders?

Yes, Aerovate Therapeutics, Inc. (AVTE) currently offers a dividend yield of approximately 14.09%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Aerovate Therapeutics, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Aerovate Therapeutics, Inc.'s intraday price range?

Today, Aerovate Therapeutics, Inc. (AVTE) stock has traded in a range of $2.63 — $2.77. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring AVTE's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Aerovate Therapeutics, Inc. stock data?

AlphaPilot sources real-time AVTE stock quotes, fundamental financial data, and historical price charts for Aerovate Therapeutics, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Aerovate Therapeutics, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of AVTE stock performance.